Papers

3

Total Citations

52

H-Index

3

About

Ataru Igarashi is a leading figure in the advancement of minimally invasive surgical oncology, with a primary focus on robotic and laparoscopic approaches for gastric and rectal cancers. His work is pivotal in defining the long-term benefits of robotic surgery, moving beyond established short-term advantages. Igarashi’s landmark 2022 multi-institutional study on robotic versus laparoscopic gastrectomy for early-stage gastric cancer (42 citations) provided critical three-year outcome data, helping to validate the robotic approach for this common malignancy. More recently, his 2025 studies on rectal cancer have broken new ground. One key paper demonstrates a significant improvement in 5-year survival with robot-assisted resection for locally advanced rectal cancer compared to both laparoscopic and open surgery—a finding that challenges existing treatment paradigms. Another large-scale database study confirms superior short- and long-term outcomes for robotic surgery in rectal cancer. Collectively, Igarashi’s research provides the highest level of evidence supporting the oncologic safety and survival benefits of robotic platforms, directly influencing surgical guidelines and practice patterns for gastrointestinal malignancies.

Research Focus

Key Achievements

3
H-Index
3
Papers
52
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Three-year outcomes of robotic gastrectomy versus laparoscopic gastrectomy for the treatment of clinical stage I/II gastric cancer: a multi-institutional retrospective comparative study
42 citations · 2022
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: The University of Tokyo, University of Tokyo Health Sciences, Department of Health

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago